Studies of patients with ovarian cancer have identified the cancer antigen CA125 as a Msln ligand (Pastan and Hassan, 2014), which is widely used as a diagnostic marker (with the exception of liver and lung cirrhosis which are considered as “false positives” (Scholler and Urban, 2007). Here, MSLN is linked to ovarian carcinoma.